CXCR4 and breast cancer: Rovito et al. demonstrated that PPARγ activation downregulates CXCR4 gene expression through recruitment of the silencing mediator of retinoid and thyroid hormone receptor (SMRT) corepressor to PPRE within the CXCR4 promoter and then inhibits breast cancer cell migration and invasion [33].